| Cytokine release syndrome A Shimabukuro-Vornhagen, P Gödel, M Subklewe, HJ Stemmler, ... Journal for immunotherapy of cancer 6, 1-14, 2018 | 1547 | 2018 |
| COVID‐19 associated pulmonary aspergillosis P Koehler, OA Cornely, BW Böttiger, F Dusse, DA Eichenauer, F Fuchs, ... Mycoses 63 (6), 528-534, 2020 | 612 | 2020 |
| The role of B cells in the pathogenesis of graft-versus-host disease A Shimabukuro-Vornhagen, MJ Hallek, RF Storb, ... Blood, The Journal of the American Society of Hematology 114 (24), 4919-4927, 2009 | 345 | 2009 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 271 | 2021 |
| Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials A Shimabukuro-Vornhagen, H Haverkamp, A Engert, L Balleisen, ... Journal of clinical oncology 23 (24), 5739-5745, 2005 | 139 | 2005 |
| Characterization of tumor-associated B-cell subsets in patients with colorectal cancer A Shimabukuro-Vornhagen, HA Schlößer, L Gryschok, J Malcher, ... Oncotarget 5 (13), 4651, 2014 | 137 | 2014 |
| Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma A Lechner, H Schlößer, SI Rothschild, M Thelen, S Reuter, P Zentis, ... Oncotarget 8 (27), 44418, 2017 | 134 | 2017 |
| Critical care of patients with cancer A Shimabukuro‐Vornhagen, B Boell, M Kochanek, E Azoulay, ... CA: a cancer journal for clinicians 66 (6), 496-517, 2016 | 129 | 2016 |
| Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma A Lechner, HA Schlößer, M Thelen, K Wennhold, SI Rothschild, R Gilles, ... Oncoimmunology 8 (3), 1535293, 2019 | 125 | 2019 |
| Functional activity of natural antibody is altered in Cr2-deficient mice RR Reid, S Woodcock, A Shimabukuro-Vornhagen, WG Austen, L Kobzik, ... The Journal of Immunology 169 (10), 5433-5440, 2002 | 116 | 2002 |
| Physical exercise modulates the homeostasis of human regulatory T cells M Weinhold, A Shimabukuro-Vornhagen, A Franke, S Theurich, P Wahl, ... Journal of Allergy and Clinical Immunology 137 (5), 1607-1610. e8, 2016 | 112 | 2016 |
| In the eye of the storm: immune-mediated toxicities associated with CAR-T cell therapy JG Borrega, P Gödel, MA Rüger, ÖA Onur, A Shimabukuro-Vornhagen, ... Hemasphere 3 (2), e191, 2019 | 105 | 2019 |
| Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults—a systematic review and meta-analysis U Holtick, M Albrecht, JM Chemnitz, S Theurich, ... Critical reviews in oncology/hematology 94 (2), 179-188, 2015 | 99 | 2015 |
| B cell-based cancer immunotherapy K Wennhold, A Shimabukuro-Vornhagen, M von Bergwelt-Baildon Transfusion Medicine and Hemotherapy 46 (1), 36-46, 2019 | 96 | 2019 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 93 | 2023 |
| CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants M von Bergwelt-Baildon, A Shimabukuro-Vornhagen, A Popov, ... Blood 107 (7), 2786-2789, 2006 | 93 | 2006 |
| Brentuximab vedotin combined with donor lymphocyte infusions for early relapse of Hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity … S Theurich, J Malcher, K Wennhold, A Shimabukuro-Vornhagen, ... Journal of Clinical Oncology 31 (5), e59-e63, 2013 | 88 | 2013 |
| Intensive care management of influenza-associated pulmonary aspergillosis P Koehler, M Bassetti, M Kochanek, A Shimabukuro-Vornhagen, ... Clinical Microbiology and Infection 25 (12), 1501-1509, 2019 | 86 | 2019 |
| Consensus statement for cancer patients requiring intensive care support MG Kiehl, G Beutel, B Böll, D Buchheidt, R Forkert, V Fuhrmann, P Knöbl, ... Annals of hematology 97, 1271-1282, 2018 | 84 | 2018 |
| OCTET‐CY: a phase II study to investigate the efficacy of post‐transplant cyclophosphamide as sole graft‐versus‐host prophylaxis after allogeneic peripheral blood stem cell … U Holtick, JM Chemnitz, A Shimabukuro‐Vornhagen, S Theurich, ... European journal of haematology 96 (1), 27-35, 2016 | 79 | 2016 |
Michael HallekUniversity of Cologne在 uni-koeln.de 的电子邮件经过验证
